CCND1 and acute myeloid leukemia: Our study showed that IRE1α inhibitors significantly increased pre- and mature miR-34a mRNA levels, associated with inhibition of CDK4, c-Myc, Bcl-2 and Cyclin D1 and induction of p21cip1 and p27kip1 in AML cells.